SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000882104-21-000035
Filing Date
2021-03-29
Accepted
2021-03-26 18:32:27
Documents
137
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K pdli-20201231.htm   iXBRL 10-K 3877489
2 EX-4.8 pdli1231202010-kex48.htm EX-4.8 13636
3 EX-10.75 pdli1231202010-kex1075.htm EX-10.75 288988
4 EX-21.1 pdli1231202010-kex211.htm EX-21.1 3718
5 EX-31.1 pdli1231202010-kex311.htm EX-31.1 8152
6 EX-31.2 pdli1231202010-kex312.htm EX-31.2 8164
7 EX-32.1 pdli1231202010-kex321.htm EX-32.1 8432
13 pdli-20201231_g1.jpg GRAPHIC 123123
14 pdli-20201231_g2.jpg GRAPHIC 271088
  Complete submission text file 0000882104-21-000035.txt   20352112

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20201231.xsd EX-101.SCH 139345
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20201231_cal.xml EX-101.CAL 173655
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20201231_def.xml EX-101.DEF 1006062
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20201231_lab.xml EX-101.LAB 1552567
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20201231_pre.xml EX-101.PRE 1281543
15 EXTRACTED XBRL INSTANCE DOCUMENT pdli-20201231_htm.xml XML 3122543
Mailing Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521
Business Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19756 | Film No.: 21778982
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences